Nationwide settlements have been reached to resolve opioid litigation brought by states and local governments. These settlements will provide substantial funds to state and local governments to combat the opioid epidemic.
“From the first day of my administration, I made combatting the drug epidemic a top priority, and that includes holding accountable those who created and fueled this crisis. I want to thank the Attorney General and his office for their work on this settlement that will help fund prevention, education and treatment efforts. No amount of money can undo the devastating toll inflicted by the opioid epidemic, but this is another step toward helping Hoosier families recover from this national crisis.”
The Office of Drug Prevention, Treatment, and Enforcement in partnership with the Indiana Family and Social Services Administration – Division of Mental Health and Addiction and the Indiana Department of Health is developing a framework for how the State of Indiana plans to use the state portion of funds from the national opioid settlement with distributors McKesson, Cardinal Health and AmerisourceBergen and manufacturer Janssen Pharmaceuticals, Inc. and its parent company Johnson & Johnson.
The State is using the Johns Hopkins Bloomberg School of Public Health’s five guiding principles to ensure dollars are used most effectively:
- Spend the money to save lives.
- Use evidence to guide spending.
- Invest in youth prevention.
- Focus on racial equity.
- Develop a fair and transparent process for deciding where to spend the funds.
Source: Next Level Recovery
State Board of Accounts
State Board of Accounts has issued a memorandum for funds that states:
In preparation for the distribution of the Opioid Settlement Funds, we have established two funds to account for the settlement transactions and provide transparency for reporting on the use of funds.
Fund 2256 Opioid Settlement Unrestricted
Fund 2257 Opioid Settlement Restricted
In addition, SBOA has released a List of Opioid Remidiation Uses.